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Abstract
Background: Patient-Reported Outcome Measures (PROMs) have been proposed for benchmarking health care
quality across hospitals, which requires extensive case-mix adjustment. The current study’s aim was to develop and
compare case-mix models for mortality, a functional outcome, and a patient-reported outcome measure (PROM) in
ischemic stroke care.
Methods: Data from ischemic stroke patients, admitted to four stroke centers in the Netherlands between 2014
and 2016 with available outcome information (N = 1022), was analyzed. Case-mix adjustment models were
developed for mortality, modified Rankin Scale (mRS) scores and EQ-5D index scores with respectively binary
logistic, proportional odds and linear regression models with stepwise backward selection. Predictive ability of these
models was determined with R-squared (R2) and area-under-the-receiver-operating-characteristic-curve (AUC)
statistics.
Results: Age, NIHSS score on admission, and heart failure were the only common predictors across all three case-
mix adjustment models. Specific predictors for the EQ-5D index score were sex (β = 0.041), socio-economic status
(β = − 0.019) and nationality (β = − 0.074). R2-values for the regression models for mortality (5 predictors), mRS score
(9 predictors) and EQ-5D utility score (12 predictors), were respectively R2 = 0.44, R2 = 0.42 and R2 = 0.37.
Conclusions: The set of case-mix adjustment variables for the EQ-5D at three months differed considerably from
the set for clinical outcomes in stroke care. The case-mix adjustment variables that were specific to this PROM were
sex, socio-economic status and nationality. These variables should be considered in future attempts to risk-adjust for
PROMs during benchmarking of hospitals.
Keywords: Ischemic stroke, Case-mix, Risk adjustment model, Patient-reported outcome measure, Value-based
healthcare
Background
The growing trend to benchmark certain health care
performance indicators – to assess the health care qual-
ity between institutions – requires careful consideration
of the methodology that is being used [1, 2]. Healthcare
is evolving towards a value-based healthcare framework
with more emphasis on Patient-Reported Outcome Mea-
sures (PROMs), that will not only facilitate opportunities
for performance improvement at an individual patient
level when these measures are used in clinical practice,
but may also be useful for benchmarking across pro-
viders [3–5]. PROMs can be defined as feedback directly
from the individual patient on their own health condi-
tion (e.g. symptoms and health-related quality of life),
thus without external interpretation [6]. PROMs can be
either disease-specific (e.g. Neuro-QOL [7]) or generic
(e.g. EQ-5D [8]).
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An important consideration for meaningful compari-
sons across hospitals is the case-mix adjustment of the
patient populations for each health care provider [9, 10].
By adjusting for the heterogeneity of patient characteris-
tics in inter-hospital comparisons, a larger part of the es-
timated variation between hospital performances will be
attributable to the quality of care provided to patients
rather than factors outside of the healthcare providers’
control.
In stroke, the most commonly used clinical outcome
measures are mortality and the modified Rankin Scale
(mRS). There has been considerable research conducted
on prognostic models for these clinical outcomes, which
also encompass variables for case-mix adjustment [11].
Although there is a strong trend to use PROMs for
benchmarking purposes [12], there still remains a lack of
case-mix models to predict patient-reported outcomes
as compared to clinical outcomes [11]. The aim of this
study was to identify the specific variables for case-mix
adjustment for a generic PROM (EQ-5D) and compare
them to case-mix variables for clinical outcomes in acute
ischemic stroke.
Methods
Patient population and data collection
A core set of baseline patient characteristics, perform-
ance indicators and outcome measures were registered
from March 2014 till August 2016 of four stroke care
centers in the Netherlands, of which 1 was a university
and 3 were district-based hospitals. The original data-
base contained consecutive acutely admitted ischemic
stroke patients of which demographic, process indicators
and outcome measures were registered.
The three outcome measures were mortality at 3
months, modified Rankin Scale (mRS) score at 3 months
and EuroQol-5D index score at 3 months. The mRS is a
commonly used clinician-reported scale, which measures
the degree of disability after a stroke, with scores ranging
from 0 to 6 (Fig. 1) [13]. The mRS score at 3 months
post-discharge was generally recorded by trained nurses,
either by phone or at the outpatient clinic. The EQ-6D,
a generic health-related quality of life (HRQOL) instru-
ment, is based on the EQ-5D (dimensions: usual activ-
ities, self-care or autonomy, mobility, pain/discomfort,
and anxiety/ depression) with an additional question on
cognitive functioning. The survey has been translated
into Dutch and validated in previously published litera-
ture [8, 14, 15]. The post-discharge EQ-6D data was cap-
tured through either face-to-face or telephone interviews
with patients themselves or their proxies. Due to the
lack of a validated EQ-6D index tariff, the utility score
was derived and transformed through the EQ-5D index
tariff, by ignoring the “cognitive” dimension of the EQ-
6D [16–18]. This EQ-5D tariff is an algorithm for
attaching values to all 3125 health states often used in
economic evaluations. This utility score can be used to
compare to population norms or to calculate quality-
adjusted life years (QALY’s) [16, 17, 19]. The authors
will, for the remainder of this article, solely mention
“EQ-5D index score” as the patient-reported outcome of
interest to avoid any confusion. This EQ-5D index score
ranged from 0 (death) to 1 (perfect health) and signified
the patient’s perspective on his/ her own health. Because
there still is no consensus on the minimal clinically im-
portant difference on the EQ-5D utility score in stroke
populations [20], it was decided to keep the EQ-5D util-
ity score as a continuous outcome rather than modify it
to an ordinal outcome based on arbitrary cut-offs.
Missing baseline patient characteristics (among which
case-mix variables) were imputed 10 times using multiple
imputation in the original database (N = 2733 patients of
4 stroke centers), assuming missingness at random. Pre-
dictors (including stroke center) and outcomes also served
as indicators for the imputation model [21]. Figure 2
showcases the substantial proportion of missing mRS and
EQ-5D data that were filtered out before the three case-
mix adjustment models were developed. Thus, all three
regression models were developed using an imputed
Fig. 1 Modified Rankin Scale (mRS)
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(10 iterations) dataset also containing the “original”
1022 patients. Potential reasons for missing patient-
reported outcome data were patients being too sick to
fill questionnaires out, and loss-to-follow at 3 months
(patients being unreachable due to staying at a nursing
home/ rehabilitation center, or because of their tremen-
dous recovery).
Case-mix models
Patient characteristics that could differ between hospitals
and could be predictive of outcomes were considered
potential candidate case-mix variables and were identi-
fied based on clinical experience and past literature.
Those included: age, sex, nationality, socio-economic
status (SES), smoking, cardiovascular comorbidity (e.g.
hypertension, hyperlipidemia), stroke in past history,
diabetes, cancer, connective tissue disease, Charlson co-
morbidity index (CCI), stroke onset-door time, initial
National Institutes of Health Stroke Scale (NIHSS) score
and the presence of a caregiver. The SES was generated
by the ranking of status scores (based on neighbor-
hoods/ zip codes) that have been calculated and pub-
lished by Social and Cultural Planning Office (SCP), a
Dutch governmental institution [22, 23].
Statistical analysis
Descriptive statistics were presented as counts (percent-
ages) or median ± inter-quartile range (IQR). Nonpara-
metric tests were used where appropriate to determine
(unadjusted) differences in patient populations between
the four healthcare providers, using the Pearson chi-
squared statistic for categorical variables and the Kruskal-
Wallis test for continuous variables. A p-value < 0.05 was
considered significant. To assess the adjusted effect of the
potential case-mix independent variables, the models were
developed using logistic, ordinal and linear regression
models respectively for mortality, mRS score and EQ-5D
index score with stepwise backward selection. This step-
wise (regression-based) method initially tests all the
predictors in a regression model and subsequently elimi-
nates the least significant variables in a stepwise approach
with a certain cut-off p-value [21]. In this study, the AIC
(Akaike information criterion) [24], equivalent to p <
0.157, was used as a criterion.
For the logistic and ordinal regression models, the
odds ratios (ORs) with 95% confidence intervals (CI)
were calculated per predictor. Beta’s (ß’s) and 95% CI
were calculated for predictors in the linear regression
model. The ß coefficient indicates the change in out-
come (units on the EQ-5D index score scale) for one
unit change in the predictor variable. The ability of the
case-mix models to explain the variability (‘goodness-of-
fit’) of these 3 outcomes was expressed by calculating
the R2 (R-squared) statistics [25]. The predictors for
each model were added in consecutive order based on
the p-values (lowest to highest p-value) and coefficients.
The explained variance of each additional predictor was
demonstrated till each model was completed.
Because the R2 measure is not immediately compar-
able between different regression models (logistic vs.
ordinal vs. linear), the AUC (area-under-the receiver-
operating-characteristic-curve) statistic was also in-
cluded to get a sense of the comparability between the
three risk-adjustment models. For this additional ana-
lysis, both mRS (0–2 vs. 3–6) and EQ-5D (< 0. 65 vs. ≥
0.65) were transformed to a binary outcome variable in
order to compare the three logistic regression models.
The EQ-5D index score of 0.65 was chosen as a cut-off
value, as it was the estimated median score in this study
sample. The statistical analysis was carried out by using
IBM SPSS Statistics 21 & RStudio version 1.0.153.0-©
2009–2016 RStudio, Inc. software.
Results
Patient characteristics
In total, 1022 ischemic stroke patients were included.
The number of patients per studied hospital varied from
29 to 555 patients. 57% of total study participants were
Fig. 2 Flowchart of Study Population Selection
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men (Table 1). The unadjusted median age was signifi-
cantly different (range 70–78 years, p = 0.001) across the
four stroke care centers. Most patients (87%) were native
Dutch inhabitants. Both the Charlson Comorbidity
Index and the stroke rate in patient history were similar
across the 4 stroke patient cohorts. There was a signifi-
cant unadjusted difference (range 113–275 min, p =
0.002) in the onset-to-door time between the patient
populations of the four stroke care centers.
The 3-month mortality was 24.5% (Table 2). The un-
adjusted difference in 3-month mortality rates between
the four stroke centers was significant (p < 0.001). 581
(57%) of all patients had a favorable degree of disability
(mRS < 3). There was also a significant unadjusted differ-
ence in mRS scale scores between the four stroke cen-
ters. The median EQ-5D index score at 3 months for all
patients was 0.65 (inter-quartile range 0.10–0.83), and
the unadjusted difference across the four stroke centers
was also significant (p < 0.001). Missing mRS outcomes
were 1205/2733 (44.1%) in the original database, with
most missing mRS data being observed in stroke center
IV (192/238 = 80.7%) (data not shown).
Case-mix models
Table 3 shows the remaining predictors in the regression
models after backward selection for mortality, mRS and
EQ-5D utility scores. The “strongest” (based on lowest p-
values) independent variables in the model for mortality
were age (OR = 1.07), NIHSS score on admission (OR =
1.17) and the Charlson’s comorbidity index (OR = 1.22).
The strongest predictors for mRS at 3 months were age
(OR = 1.04), NIHSS score at admission (OR = 1.17), heart
failure (OR = 3.58) and previous stroke (OR = 1.74). There
were only three overlapping predictors for the three
Table 1 Characteristics of all Ischemic Stroke Patients (N = 1022) and per Dutch Stroke Center, Admitted from March 2014 – August
2016 in Four Dutch Stroke Hospitals
Patient characteristics All patients
(N = 1022)
Stroke Center I,
University
(N = 222)
Stroke Center II,
District-based
(N = 555)
Stroke Center III,
District-based
(N = 216)
Stroke Center IV,
District-based
(N = 29)
P-value Missing data,
N (%)
Male, N (%) 578 (57) 139 (63) 315 (57) 109 (50) 15 (52) 0.076
Age, median (IQR) 74 (64–82) 70 (59–80) 76 (66–83) 72 (63–82) 78 (72–85) 0.001
Nationality 0.351 84 (8)
Native Dutch 888 (87) 171 (77) 517 (93) 174 (81) 26 (90)
Foreigner 50 (5) 9 (4) 34 (6) 5 (2) 2 (7)
Smoking, N (%) 225 (22) 51 (23) 131 (24) 37 (17) 6 (21) 0.604 72 (7)
SES, N (%) < 0.001 8 (1)
Low 335 (33) 101 (45) 131 (24) 81 (38) 22 (76)
Middle 427 (42) 94 (42) 214 (39) 119 (55) 0 (0)
High 252 (25) 25 (11) 207 (37) 15 (7) 5 (17)
NIHSS on admission, median (IQR) 4 (2–12) 5 (2–9) 4 (2–14) 3 (1–8) 3 (2–14) 0.028 75 (7)
CCI, median (IQR) 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–2) 1 (0–3) 0.133 89 (9)
Comorbidities, N (%)
Hypertension 546 (53) 123 (55) 332 (60) 74 (34) 17 (59) < 0.001 9 (1)
Myocardial infarction 103 (10) 15 (7) 71 (13) 17 (8) 0 (0) 0.012 15 (2)
Heart failure 66 (7) 2 (1) 52 (9) 8 (4) 4 (15) < 0.001 22 (2)
Previous stroke/TIA 274 (27) 58 (26) 156 (28) 54 (25) 6 (21) 0.745 10 (1)
Carotid stenosis 64 (6) 11 (5) 44 (8) 8 (4) 1 (3) 0.093 50 (5)
PAOD 80 (8) 13 (6) 46 (8) 17 (8) 4 (14) 0.374 14 (1)
Diabetes mellitus 39 (4) 9 (4) 25 (5) 4 (2) 1 (3) 0.409 15 (2)
Connective tissue disease 26 (3) 0 (0) 13 (2) 13 (6) 0 (0) < 0.001 24 (2)
Cancer 112 (11) 32 (14) 44 (8) 34 (16) 2 (7) 0.004 6 (1)
Metastasis 24 (2) 8 (4) 10 (2) 5 (2) 1 (3) 0.514 27 (3)
Caregiver post-discharge, N (%) 563 (55) 140 (63) 292 (53) 121 (56) 10 (34) 0.066 150 (15)
Onset-to-door time,
median minutes (IQR)
213 (80–672) 275 (72–959) 215 (93–641) 149 (63–384) 113 (41–368) 0.002 153 (15)
IQR Inter-quartile range, SES Socio-economic status, derived from status scores based on zip codes, NIHSS National Institute of Health Stroke Scale, CCI Charlson
comorbidity index, TIA Transient ischemic attack, PAOD Peripheral arterial occlusive disease
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different outcomes: age, NIHSS score on admission and
heart failure. Exclusive predictors for the EQ-5D index
score were sex (β = 0.041), socio-economic status (β = −
0.019), and nationality (β = − 0.074).
The binary logistic regression model for mortality had
an R2 = 0.44 (Table 3), compared to the ordinal
regression model for the mRS which had an R2 = 0.42,
and the linear regression model for the EQ-5D utility
score with a R2 = 0.37. The largest increase in R2 was
after the addition of NIHSS to the models for mortality
and mRS, and age to the EQ-5D index score model
(Fig. 3). After mRS and EQ-5D index scores were both
Table 2 Outcome Measures of Ischemic Stroke Patients (N = 1022)
Outcome variables All patients
(N = 1022)
Stroke Center I,
University (N = 222)
Stroke Center II,
District-based
(N = 555)
Stroke Center III,
District-based
(N = 216)
Stroke Center IV,
District-based
(N = 29)
P-value
mRS at 3 months, N (%) < 0.001
0 89 (8.7) 37 (16.7) 25 (4.5) 27 (12.5) 0
1 262 (25.6) 62 (27.9) 143 (25.8) 53 (24.5) 4 (13.8)
2 230 (22.5) 37 (16.7) 130 (23.4) 58 (26.9) 5 (17.2)
3 108 (10.6) 23 (10.4) 67 (12.1) 15 (6.9) 3 (10.3)
4 68 (6.7) 24 (10.8) 32 (5.8) 11 (5.1) 1 (3.4)
5 15 (1.5) 2 (0.9) 11 (2.0) 2 (0.9) 0
6 250 (24.5) 37 (16.7) 147 (26.5) 50 (23.1) 16 (55.2)
EQ-5D index score at 3
months, median (IQR)
0.65 (0.1–0.83) 0.781 (0.45–1.00) 0.61 (0–0.78) 0.65 (0.28–0.83) 0 (0–0.60) < 0.001
mRS Modified Rankin Scale scores, EQ-5D EuroQol 5-Dimension, IQR Inter-quartile range
Table 3 Case-Mix Risk Adjustment Models for Mortality, mRS and EQ-5D
Model 1*:
Mortality
at 3 months
Model 2*:
mRS score
at 3 months
Model 3*:
EQ-5D index score
at 3 months
(Nagelkerke) R2 0.44 0.42 0.37
AUCa 0.87 0.83 0.78
Variables Multivariable OR
(95% CI)
P-value Multivariable OR (95% CI) P-value ßeta
(SE)
P-value
Age 1.07 (1.05–1.09) < 0.001 1.04 (1.03–1.05) < 0.001 −0.007 (0.001) < 0.001
NIHSS on admission 1.17 (1.14–1.20) < 0.001 1.17 (1.14–1.19) < 0.001 − 0.020 (0.001) < 0.001
Heart failure 2.54 (1.30–4.97) 0.007 3.58 (2.14–5.98) < 0.001 − 0.130 (0.042) 0.002
Previous stroke 1.74 (1.33–2.27) < 0.001 − 0.063 (0.023) 0.007
Smoking 1.58 (1.18–2.13) 0.003 − 0.055 (0.025) 0.028
Caregiver at discharge 0.67 (0.51–0.86) 0.002 0.057 (0.022) 0.010
Connective tissue disease 2.07 (0.93–4.61) 0.074 −0.119 (0.061) 0.053
Cancer 1.99 (1.35–2.94) 0.001 −0.065 (0.042) 0.122
CCI 1.22 (1.13–1.32) < 0.001 −0.020 (0.007) 0.003
Onset-to-door time (per 10 min) 1.00 (1.00–1.00) 0.123
Diabetes 2.09 (1.12–3.88) 0.020
Sex
(Ref: Female)
0.041 (0.020) 0.036
SES −0.019 (0.010) 0.053
Nationality
(Ref: Native Dutch)
−0.074 (0.045) 0.097
SES Socio-economic status, derived from neighborhood-based ranking, NIHSS National Institute of Health Stroke Scal, CCI Charlson comorbidity index, R2 R-
squared, 95% CI 95% confidence interval, SE Standard error
*The case-mix models was using backward selection with the Akaike information criterion (AIC) as a cut-off for the p-value. The imputed dataset (10 imputations
of original data N = 1022) was used for the development of all three case-mix model development
aAUC values were calculated for mortality, dichotomized mRS scores (0–2 vs. 3–6) and dichotomized EQ-5D index scores (< 0.65 vs. ≥ 0.65)
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transformed to a dichotomous outcome, AUC’s were
compared between all three binary logistic regression
models: AUC = 0.87 (mortality) vs. AUC = 0.83 (mRS ≥
3) vs. AUC = 0.78 (EQ-5D index score ≥ 0. 65). As op-
posed to the models for mortality and mRS, it took more
predictors in the model for EQ-5D index scores for the
predictive ability to reach a plateau.
Discussion
The objective of this study was to construct and com-
pare case-mix adjustment models for three different out-
comes, of which two were clinical (mortality and
modified Rankin Scale at 3 months) and one patient-
reported (EQ-5D utility score at 3 months). The three
case-mix models had several predictors in common: age,
NIHSS score at hospital admission, and heart failure.
However, the most important difference in the case-mix
adjustment models was that sex, nationality, and socio-
economic status remained significant case-mix variables
specifically for the PROM in contrast to the models for
the clinical outcomes. It has to be stated that even if a
predictor is significantly associated with the outcome, it
doesn’t necessarily have to be included as a case-mix
variable, if the prevalence distribution of the variable
and its effect on the outcome of interest is similar across
hospitals. The R-squared (R2) statistics of the model for
the patient-reported outcome measure (PROM) was
somewhat lower in comparison to the R2 statistics for
mortality and the modified Rankin Scale (mRS), but con-
tained more variables.
There have been multiple models previously developed
and validated to predict clinical outcomes after stroke
[11]. Bray et al. [26] developed and externally validated
two case-mix models with 30-day post-stroke mortality
as an outcome. The predictors included in the final
models were similar to the findings of the current study:
age, NIHSS on admission and atrial fibrillation. On the
other hand, there has not been much research con-
ducted on the development of case-mix factors for
patient-reported outcomes (e.g. EQ-5D) in stroke care
[27]. There was some overlap in the remaining case-mix
variables in this study and those identified in previously
published articles [28]. A review by Carod-Artal et al.
[29] identified age, sex, stroke severity, physical impair-
ment, functional status, and mental impairment as pre-
dictors for the health-related quality of life (HRQOL)
after stroke. Mar et al. [30] also found the male gender
and the NIHSS to be significantly associated with better
EQ-5D values. The negative association between (history
of) cancer and a lower quality of life (lower EQ-5D
scores) in this study confirms previously published
literature [23, 31, 32].
A striking observation is the caregiver presence post-
discharge as a statistically significant predictor variable
for mRS score at 3 months with an OR = 0.67 (95% CI
0.51–0.86; p = 0.002) and for the EQ-5D utility score at
3 months with a ßeta = 0.057 (SE 0.022). This observa-
tion of caregiver presence at hospital discharge being as-
sociated with a lower mRS score (better clinical
outcome) and a higher EQ-5D utility score (better qual-
ity of life) at 3 months, highlights the potential benefits
that a caregiver could offer (e.g. patient motivation, fa-
cilitating rehabilitative care) leading to improved func-
tional status and quality of life. However, definite
conclusions cannot be drawn about this association, be-
cause the definition of “caregiver” and “caregiver pres-
ence” was not similar across the multiple stroke centers;
it was unclear if the absence of a caregiver implied no
indication (e.g. low mRS score) or no need (admittance
to a revalidation center or nursing home).
Strengths and limitations
A considerable strength of this study is that it explores a
relatively new field of research namely case-mix
Fig. 3 Prognostic Value of Univariable and Full Models for Three Outcomes, Expressed in Percentage Explained Variance (R2)
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adjustments for PROMs in order to make inter-hospital
performance comparisons. The case-mix variables for a
PROM do not imply additional registration burden for
recording data in quality registries because general (rele-
vant) demographic variables (e.g. age, gender and socio-
economic status) are already captured in standardized
fashion. This is a major strength of the study.
An important limitation of this study is the notably
large amount of missing outcome (mRS and EQ-5D)
data in the original database. This problem is not un-
common in registries that are routinely acquired for the
purpose of quality of care assessment, and it was the
main reason this study solely focused on the develop-
ment of case-mix risk adjustment models rather than
benchmarking the included stroke centers. Although the
estimated regression coefficients of all three case-mix
models might be somewhat biased due to the substantial
missingness, it is less important in this context and more
about the differences in case-mix variables between the
models. The missing data issue was partially countered by
the use of multiple imputation for the predictor variables.
The distribution of patient characteristics was compared
between missing and non-missing mRS and EQ-5D
groups (data not shown). These analyses showed signifi-
cant differences in distribution in NIHSS score, SES rank
(low, middle, high), nationality, and some cardiovascular
comorbidities (hypertension, heart failure, hyperlipidemia)
between missing and non-missing mRS and EQ-5D data.
This observation implies that the generalizability of the
final set of case-mix variables, observed in this study,
should be corroborated in future research.
Another limitation is the loss-to-follow-up bias in
this stroke registry: if missing 3-month mRS and EQ-
5D data could be attributed to either patients’ full re-
covery or an extended stay in a rehabilitation center/
nursery home, it is quite possible that known out-
come data could be skewed (both directionalities pos-
sible), seeing it was mostly recorded at outpatient
clinics. Other stroke registries (e.g. European Safe Im-
plementation of Thrombolysis in Stroke-Monitoring
Study (SITS-MOST) [33] and UK Sentinel Stroke Na-
tional Audit Program (SSNAP) [34]) have also incor-
porated patient-reported outcomes, which are
typically collected at 3–6 months post-discharge
through diverse methods like face-to-face interviews,
telephone interviews or mailed questionnaires [35]. As
the collection of PROMs at these time points can be
challenging due to varying post-discharge patient tra-
jectories and/ or substantial resource requirements
(personnel and costs), future research should focus on
efficient methods to optimally capture PROM data as
part of value-based stroke care. This is an essential
step that should to be taken before (case-mix) risk
adjustment models are further developed.
In this study, R2 values were compared to pseudo-R2
values although they are not directly comparable. How-
ever, the objective of this study was to showcase the dif-
ferences in predictors between the three models. It has
to be noted that some potentially relevant psychological
case-mix variables (e.g. depression, anxiety, EQ-5D
scores at baseline) were not recorded in the database,
even though they could influence PROM responses and
thus ultimately impact the case-mix adjustment model.
This paper suggests that the specific predictors for the
EQ-5D, based on this data, have not been found yet.
Conclusions
In conclusion, this study shows that other predictors
(e.g. psychological and social factors) should be consid-
ered as potential case-mix variables for patient-reported
outcome measures (PROMs) than for clinical outcomes
in ischemic stroke patients. It is important that these
specific case-mix variables should be included in order
to benchmark hospitals legitimately on PROMs. One of
the principles of value-based healthcare is to benchmark
clinical outcomes and PROMs across different diseases
and healthcare providers/ institutions to ensure quality
improvement and competition [36]. This study identified
a low (er) socio-economic status to be specifically associ-
ated with lower EQ-5D index scores. Future research
should focus on finding other important predictors spe-
cific to PROMs in acute ischemic stroke to be able to
further develop valid case-mix models.
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